Loading the security overview…
Where the tokens are
| Quarter | Reported | EPS | EPS vs year ago | Revenue | Revenue vs year ago | Consensus EPS |
|---|---|---|---|---|---|---|
| Q2 FY26ended Jun 30, 2026 | Aug 5, 2026 | $1.09 | +5.8% | $19.15B | +10.5% | $2.30 |
| Q1 FY26ended Mar 31, 2026 | May 6, 2026 | $1.74 | +35.9% | $19.07B | +2.7% | $2.25 |
| Q4 FY25ended Dec 31, 2025 | — | $1.18 | −33.7% | $23.81B | +27.6% | — |
| Q3 FY25ended Sep 30, 2025 | — | $1.22 | −32.6% | $17.36B | −5.9% | — |
| Q2 FY25ended Jun 30, 2025 | — | $1.03 | −19.5% | $17.34B | −2.7% | — |
| Q1 FY25ended Mar 31, 2025 | — | $1.28 | +16.4% | $18.57B | +15.6% | — |
| Q4 FY24ended Dec 31, 2024 | — | $1.78 | +131.2% | $18.67B | −1.9% | — |
| Q3 FY24ended Sep 30, 2024 | — | $1.81 | +223.2% | $18.44B | +16.2% |
Growth compares each quarter with the same fiscal quarter a year earlier, and is left blank where that quarter is missing or its figure was zero or a loss. Consensus is the estimate published before each report. It usually refers to adjusted EPS, so it is shown beside the GAAP figure rather than subtracted from it: the difference would not be a beat or a miss.
Figures describe MetLife shares, not any token. As of Aug 5, 2026, from Massive's standardised financials and the earnings calendar.
| — |
| Q2 FY24ended Jun 30, 2024 | — | $1.28 | — | $17.82B | — | — |
| Q1 FY24ended Mar 31, 2024 | — | $1.10 | — | $16.06B | — | — |
| Q4 FY23ended Dec 31, 2023 | — | $0.77 | — | $19.03B | — | — |
| Q3 FY23ended Sep 30, 2023 | — | $0.56 | — | $15.87B | — | — |